Sensei Biotherapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Sensei Biotherapeutics has a total shareholder equity of $52.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $59.8M and $7.6M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
US$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$52.29m |
| Aandelen | US$52.19m |
| Totaal verplichtingen | US$7.61m |
| Totaal activa | US$59.80m |
Recente financiële gezondheidsupdates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03
We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14Recent updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
Aug 09Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Apr 18Sensei Biotherapeutics (NASDAQ:SNSE) Is In A Good Position To Deliver On Growth Plans
Nov 16Analyse van de financiële positie
Kortlopende schulden: SNSE's short term assets ($53.9M) exceed its short term liabilities ($4.9M).
Langlopende schulden: SNSE's short term assets ($53.9M) exceed its long term liabilities ($2.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: SNSE is debt free.
Schuld verminderen: SNSE currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: SNSE has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: SNSE has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 16.5% each year.